Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-04-16

Clinical Trial Update: Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203

View source ↗

Summary

A registry update to monitor safety in subjects who completed Juventas' heart failure protocol under IND 14203.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Juventas Therapeutics, Inc. | Conditions: Ischemic Heart Failure | Status: UNKNOWN